The prognostic significance of elevated serum CA19-9 level in patients with metastatic colorectal cancer

被引：0
|
作者：
Wong, A
Chan, AKP
机构：
[1] Tom Baker Canc Clin, Calgary, AB, Canada
[2] Univ Calgary, Calgary, AB, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80663-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
230
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [21] CA19-9 as a predictor of recurrence in patients with colorectal cancer
    Nakayama, T
    Watanabe, M
    Teramoto, T
    Kitajima, M
    JOURNAL OF SURGICAL ONCOLOGY, 1997, 66 (04) : 238 - 243
  • [22] Prognostic Value of Serum Tumor Antigen CA19-9 After Curative Resection of Colorectal Cancer
    Park, In Ja
    Choi, Gyu-Seog
    Jun, Soo Han
    ANTICANCER RESEARCH, 2009, 29 (10) : 4303 - 4308
  • [23] Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
    Morita, S
    Nomura, T
    Fukushima, Y
    Morimoto, T
    Hiraoka, N
    Shibata, N
    DISEASES OF THE COLON & RECTUM, 2004, 47 (02) : 227 - 232
  • [24] The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer
    Kodera, Y
    Yamamura, Y
    Torii, A
    Uesaka, K
    Hirai, T
    Yasui, K
    Morimoto, T
    Kato, T
    Kito, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (01): : 49 - 53
  • [25] Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer
    Kochi M.
    Fujii M.
    Kanamori N.
    Kaiga T.
    Kawakami T.
    Aizaki K.
    Kasahara M.
    Mochizuki F.
    Kasakura Y.
    Yamagata M.
    Gastric Cancer, 2000, 3 (4) : 177 - 186
  • [26] Ruptured large hepatic cyst with elevated serum and ascites CA19-9 level
    Mizukami, Ryosuke
    Nakazawa, Akiko
    Einama, Takahiro
    Kariya, Risa
    Ohara, Mayuko
    Ichio, Koki
    Konno, Fukumi
    Kobayashi, Kazuki
    Yonamine, Naoto
    Fujinuma, Ibuki
    Tsunenari, Takazumi
    Takihata, Yasuhiro
    Takao, Mikiya
    Shinto, Eiji
    Ueno, Hideki
    Kishi, Yoji
    JOURNAL OF SURGICAL CASE REPORTS, 2024, 2024 (08):
  • [27] ELEVATED CA19-9 AS THE MOST SIGNIFICANT PROGNOSTIC FACTOR IN ADVANCED COLORECTAL-CARCINOMA
    KOURI, M
    PYRHONEN, S
    KUUSELA, P
    JOURNAL OF SURGICAL ONCOLOGY, 1992, 49 (02) : 78 - 85
  • [28] Serum CA19-9 response is an early predictive marker for the efficacy of regorafenib in refractory metastatic colorectal cancer
    Komori, A.
    Taniguchi, H.
    Kito, Y.
    Hamauchi, S.
    Masuishi, T.
    Hasegawa, H.
    Mitani, S.
    Narita, Y.
    Kadowaki, S.
    Ura, T.
    Ando, M.
    Mori, K.
    Yasui, H.
    Muro, K.
    Yamazaki, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 51 - 52
  • [29] CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma
    Lyu, Shao-Cheng
    Wang, Jing
    Huang, Mengxiu
    Wang, Han-Xuan
    Zhou, Lin
    He, Qiang
    Lang, Ren
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4887 - 4898
  • [30] Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer
    Jo, Jae-Cheol
    Ryu, Min-Hee
    Koo, Dong-Hoe
    Ryoo, Baek-Yeol
    Kim, Hwa Jung
    Kim, Tae Won
    Choi, Kee Don
    Lee, Gin Hyug
    Jung, Hwoon-Yong
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Jin-Ho
    Kang, Yoon-Koo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 324 - 330
12345